MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 181 filers reported holding MANNKIND CORP in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,702 | +1.5% | 412 | 0.0% | 0.00% | – |
Q2 2023 | $1,677 | -0.7% | 412 | 0.0% | 0.00% | – |
Q1 2023 | $1,689 | -22.2% | 412 | 0.0% | 0.00% | – |
Q4 2022 | $2,171 | – | 412 | +224.4% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 127 | +27.0% | 0.00% | – |
Q2 2021 | $1,000 | – | 100 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 100 | -98.0% | 0.00% | -100.0% |
Q3 2020 | $10,000 | -61.5% | 5,100 | -66.2% | 0.00% | -62.5% |
Q2 2020 | $26,000 | +160.0% | 15,100 | +49.5% | 0.01% | +100.0% |
Q1 2020 | $10,000 | -47.4% | 10,100 | -33.1% | 0.00% | -42.9% |
Q4 2019 | $19,000 | -5.0% | 15,100 | -3.5% | 0.01% | -12.5% |
Q3 2019 | $20,000 | +53.8% | 15,640 | +34.4% | 0.01% | +60.0% |
Q2 2019 | $13,000 | -27.8% | 11,640 | +20.7% | 0.01% | -28.6% |
Q1 2019 | $18,000 | +50.0% | 9,640 | -17.2% | 0.01% | +16.7% |
Q4 2018 | $12,000 | – | 11,640 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
1492 Capital Management LLC | 533,828 | $2,333,000 | 1.15% |
180 WEALTH ADVISORS, LLC | 1,037,426 | $3,932,000 | 0.88% |
EMERALD ADVISERS, LLC | 5,217,037 | $22,798,000 | 0.84% |
EMERALD MUTUAL FUND ADVISERS TRUST | 4,648,971 | $20,316,000 | 0.72% |
Avoro Capital Advisors LLC | 8,800,000 | $38,456,000 | 0.65% |
Monarch Partners Asset Management LLC | 420,478 | $1,837,000 | 0.37% |
DG Capital Management, LLC | 511,562 | $2,236,000 | 0.37% |
Bruce & Co., Inc. | 395,073 | $1,726,000 | 0.34% |
SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $3,037,000 | 0.29% |
Parkman Healthcare Partners LLC | 265,855 | $1,162,000 | 0.26% |